Semaglutide Shows Major Benefits in PAD: STRIDE

The GLP-1 agonist has shown convincing benefits in yet another population, patients with peripheral arterial disease, in a practice-changing trial, according to experts.
Medscape Medical News

source https://www.medscape.com/viewarticle/semaglutide-shows-major-benefits-peripheral-arterial-disease-2025a10007kp?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?